Certified by Founder Lodge
Kate Therapeutics
United States - San Diego, California
START UP
1 Disclosed Funding Rounds $51,000,000
0 Participating Investments
-
Founded date
2020
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Kate Therapeutics (KateTx) is a patient-focused biotechnology company developing adeno-associated virus (AAV)-based gene therapies to treat genetically defined muscle and heart diseases. The
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| June, 08 ,2023 | Series A | $51,000,000 |
Osage University Partners (OUP)
Versant Ventures
Westlake Village BioPartners®
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Allos | $5,000,000 | (Jan 14, 2026)
Nodu | $1,450,000 | (Jan 14, 2026)
Diagonal Therapeutics | $125,000,000 | (Jan 13, 2026)
BlueNalu | $11,000,000 | (Jan 13, 2026)
encoord | $2,000,000 | (Jan 13, 2026)
